Compare RXRX & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXRX | TDC |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 2021 | 2007 |
| Metric | RXRX | TDC |
|---|---|---|
| Price | $2.88 | $24.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $7.50 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 11.5M | 1.8M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.79 | ★ 16.38 |
| EPS | N/A | ★ 1.35 |
| Revenue | $74,681,000.00 | ★ $2,156,000,000.00 |
| Revenue This Year | $12.11 | $0.30 |
| Revenue Next Year | $82.52 | $1.38 |
| P/E Ratio | ★ N/A | $18.75 |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.91 | $18.43 |
| 52 Week High | $7.18 | $41.78 |
| Indicator | RXRX | TDC |
|---|---|---|
| Relative Strength Index (RSI) | 28.02 | 31.77 |
| Support Level | N/A | $20.48 |
| Resistance Level | $5.03 | $32.03 |
| Average True Range (ATR) | 0.17 | 1.02 |
| MACD | -0.03 | -0.16 |
| Stochastic Oscillator | 9.72 | 4.19 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.